Keyword: AmbioPharm


AmbioPharm Appoints Brian Gregg as CEO

04.10.2023 -

Contract development and manufacturing organization (CDMO) AmbioPharm has appointed industry veteran Brian Gregg as CEO. Gregg, who has more than 30 years of experience...


Ariceum and AmbioPharm in Peptide Partnership

07.11.2022 -

Ariceum Therapeutics, a Berlin-headquartered private biotech developing radiopharmaceutical products for the diagnosis and systemic targeted certain hard-to-treat cancers...

Chemistry & Life Sciences

Streamlining the Path to Peptide Market Supply

16.03.2021 -

Interview with Michael Postlethwaite, Senior Director, Sales & Business Development, European Territories, AmbioPharm


AmbioPharm Opens Shanghai Campus, Establishes Office in Switzerland

15.01.2021 -

AmbioPharm, a CDMO specializing in peptide active pharmaceutical ingredients (APIs), has opened its new Shanghai campus, adding nearly 50,000 square meters of...